A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
R$ ५९.८४
०.००%
(०.००) 1D
अक्टोबर १६, १६:५६:०० GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1LN34...
Open
R$ ५९.२८
High
R$ ५९.८४
Low
R$ ५९.२८
Mkt. cap
३१.०२ अरब
Avg. vol.
४४६.००
Volume
१७.००
52-wk high
R$ १३१.८०
52-wk low
R$ ५०.२५
Shares outstanding
१३.३८ करोड
No. of employees
२ हजार
Open
R$ ५९.२८
High
R$ ५९.८४
Low
R$ ५९.२८
Mkt. cap
३१.०२ अरब
Avg. vol.
४४६.००
Volume
१७.००
52-wk high
R$ १३१.८०
52-wk low
R$ ५०.२५
Shares outstanding
१३.३८ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
ad-hoc-news.de
·
३० मिनेट पहिले
BofA cuts target to USD 336.00 for Alnylam Pharmaceuticals stock
ad-hoc-news.de
·
१ दिन पहिले
Citigroup cuts target to USD 320 for Alnylam Pharmaceuticals stock
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals Inc Bdr